CD1C and rheumatoid arthritis: Together, our data indicate that CD1c+ cDC from RA individuals are preferentially restored after treatment initiation and are characterized by the differential expression of the cell surface marker CD64, suggesting a significant contribution of this DC subset to the perpetuation of RA pathology.